Moving more potent and less toxic options to the frontline in the management of advanced lung cancer

J Thorac Dis. 2017 Sep;9(9):2812-2818. doi: 10.21037/jtd.2017.08.79.

Authors

Xiuning Le¹, Deepa Rangachari¹, Daniel B Costa¹

Affiliation

¹ Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, US.

No abstract available

Publication types

Editorial
Comment